HPV vaccination

Inaccurate assumptions about oropharyngeal cancer

BMJ 2009; 339 doi: 10.1136/bmj.b4525 (Published 2 November 2009)
Cite this as: BMJ 2009;339:b4525

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Erich M Sturgis, associate professor1,
  2. Kristina R Dahlstrom, doctoral student2
  1. 1Department of Head and Neck Surgery and Department of Epidemiology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
  2. 2University of Texas School of Public Health, Houston, Texas, USA
  1. esturgis{at}mdanderson.org

    The article by Kim and Goldie on the cost effectiveness of including boys in a human papillomavirus (HPV) vaccination programme made assumptions about oropharyngeal cancers that are inaccurate.1 The prevalence of HPV in oropharyngeal …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL